Next Article in Journal
Effect of Microwave Treatment of Graphite on the Electrical Conductivity and Electrochemical Properties of Polyaniline/Graphene Oxide Composites
Next Article in Special Issue
Polycaprolactone/Amino-β-Cyclodextrin Inclusion Complex Prepared by an Electrospinning Technique
Previous Article in Journal
Patterned Fibers Embedded Microfluidic Chips Based on PLA and PDMS for Ag Nanoparticle Safety Testing
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Polymers
Volume 8
Issue 11
10.3390/polym8110397
polymers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Co-Delivery of Imiquimod and Plasmid DNA via an Amphiphilic pH-Responsive Star Polymer that Forms Unimolecular Micelles in Water

by
Wenjing Lin
1,2,
Na Yao
1,
Hongru Li
2,3,
Samuel Hanson
2,
Wenqing Han
2,
Chun Wang
2,* and
Lijuan Zhang
1,*
1
School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, China
2
Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455, USA
3
State Key Laboratory of Medicinal Chemical Biology and Tianjin Key Laboratory of Molecular Drug Research, College of Pharmacy, Nankai University, Tianjin 300071, China
*
Authors to whom correspondence should be addressed.
Polymers 2016, 8(11), 397; https://0-doi-org.brum.beds.ac.uk/10.3390/polym8110397
Submission received: 12 October 2016 / Revised: 8 November 2016 / Accepted: 9 November 2016 / Published: 16 November 2016
(This article belongs to the Special Issue Advance of Polymers Applied to Biomedical Applications: Biointerface)
Browse Figures
Versions Notes

Abstract

:
Dual functional unimolecular micelles based on a pH-responsive amphiphilic star polymer β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 have been developed for the co-delivery of imiquimod and plasmid DNA to dendritic cells. The star polymer with well-defined triblock arms was synthesized by combining activator regenerated by electron-transfer atom-transfer radical polymerization with ring-opening polymerization. Dissipative particle dynamics simulation showed that core-mesophere-shell-type unimolecular micelles could be formed. Imiquimod-loaded micelles had a drug loading of 1.6 wt % and a larger average size (28 nm) than blank micelles (19 nm). The release of imiquimod in vitro was accelerated at the mildly acidic endolysosomal pH (5.0) in comparison to physiologic pH (7.4). Compared with blank micelles, a higher N:P ratio was required for imiquimod-loaded micelles to fully condense DNA into micelleplexes averaging 200–400 nm in size. In comparison to blank micelleplexes, imiquimod-loaded micelleplexes of the same N:P ratio displayed similar or slightly higher efficiency of gene transfection in a mouse dendritic cell line (DC2.4) without cytotoxicity. These results suggest that such pH-responsive unimolecular micelles formed by the well-defined amphiphilic star polymer may serve as promising nano-scale carriers for combined delivery of hydrophobic immunostimulatory drugs (such as imiquimod) and plasmid DNA with potential application in gene-based immunotherapy.

1. Introduction

With advances in genomics and proteomics, many new potential antigens have been identified and can be developed into subunit vaccines in the forms of recombinant proteins and synthetic peptides, as well as genetic vaccines based on DNA. Compared with traditional vaccines comprised of attenuated or deactivated pathogens, subunit- and gene-based antigens are much safer in humans but can be poorly immunogenic. Vaccine adjuvants are capable of enhancing immunogenicity of antigens either through exerting immunostimulatory effects or by altering the process of antigen delivery. Major categories of adjuvants include killed bacteria, bacterial components, aluminum salt, oil-based emulsions, polysaccharides, and liposomes [1,2,3,4,5]. Aluminum salt (Alum) is one of the most common adjuvants approved for human use, but its use is limited by suboptimal immunostimulatory capacity and difficulties in preparation and handling [6]. More specific and potent molecular adjuvants based on ligands of toll-like receptors (TLRs) have attracted much attention in recent years—some of the well-known ones include CpG oligodeoxynucleotides (TLR9 ligand), imidazoquinolines (TLR7/8 ligand), polyinosinic-polycytidylic acid (poly(I:C), TLR3 ligand), and monophosphoryl lipid A (MPL, TLR4 ligand), just to name a few [7]. On the other hand, these highly specific immunostimulatory molecules require new and better carriers to deliver them—along with antigens—to their respective cellular and molecular targets. Liposomes, emulsions, and polymeric nanoparticles are some of the current types of delivery systems that have shown much promise in enhancing the efficacy of molecular adjuvants and vaccines [8,9,10,11].
Imiquimod (IMQ) is a synthetic small-molecule immune response modifier (adjuvant). A member of the imidazoquinoline family, IMQ binds to TLR7 and stimulates the production of cytokines that activate the immune system to recognize and defend against viral infection and cancer [12,13]. A topical cream formulation containing 5% IMQ [14], marketed by 3M Pharmaceuticals (St. Paul, MN, USA) as Aldara, has been approved by the US Food and Drug Administration (FDA) to treat actinic keratosis, superficial basal cell carcinoma, and genital warts [15,16,17]. It is reported that topically-administered IMQ activates antigen-presenting Langerhan cells in the dermis [18], but a recent finding calls into question on whether the mechanism of action of Aldara is dependent on TLR7 [19], as the free drug is, highlighting the importance of the mode of drug delivery. Since IMQ is hydrophobic with its target TLR7 located inside the cell, it is logical to consider using polymeric microparticles [20] and nanoparticles [21,22] as delivery vehicles to improve aqueous solubility and facilitate intracellular transport of the drug. As demonstrated in recent reports by Trimaille and coworkers, using core-shell-type poly(d,l-lactide)-b-poly(N-acryloxysuccinimide-co-N-vinylpyrrolidone) micelles, encapsulation of IMQ into the hydrophobic core of micelles enhanced drug solubility in water and resulted in more potent stimulation of antigen-presenting dendritic cells in vitro [21,22].
The objective of this study is to develop unimolecular micelles as nanocarriers for combined delivery of IMQ and plasmid DNA to dendritic cells. In contrast to conventional micelles reported previously for IMQ delivery that are formed by self-assembly of multiple chains of linear block copolymer [21,22], unimolecular micelles are thermodynamically stable, because each micelle constitutes a single copy of an amphiphilic star polymer that maintains its structural integrity independent of polymer concentration, temperature, and pH [23,24,25,26]. At the same time, by controlling the length and composition of the star copolymer blocks, the properties of unimolecular micelles may be readily tunable to facilitate loading and release of IMQ in response to the intracellular pH environment of the endosome where stimulation of TLR7 occurs. Furthermore, cationic blocks can be introduced so that the unimolecular micelles also acquire the ability of delivering plasmid DNA in addition to IMQ. A number of cationic polymers are being investigated for DNA vaccine delivery to antigen-presenting cells (see examples [27,28,29,30]), however, polymeric carriers for combined delivery of plasmid DNA and hydrophobic immunostimulatory drugs (e.g., IMQ) have not been reported. Such dual functional nanocarriers would be useful in gene-based vaccination and immunotherapy, given the compelling bio-based rationale for the co-delivery approach [31]. Here we described the synthesis and characterization of such a dual functional nanocarrier and examined the influence of co-delivering IMQ on gene transfection efficiency in dendritic cells in vitro.

2. Materials and Methods

2.1. Materials

β-Cyclodextrin (β-CD, 99%, J&K Scientific Ltd., Beijing, China) was recrystallized from water, mixed in solvents (n-hexane/benzene) three times, and then dried at room temperature under reduced pressure. d,l-Lactide (d,l-LA, 99%, J&K Scientific Ltd, Beijing, China) was recrystallized from ethyl acetate three times and dried at room temperature under reduced pressure. 2-(Dimethylamino)ethyl methacrylate (DMAEMA, >98%, TCI, Tokyo, Japan) was purified by passing through a column filled with neutral alumina to remove inhibitor before use. Oligo(2-ethyl-2-oxazoline)methacrylate (EtOxMA) has been synthesized and reported in our previous article [32]. Triethylamine (TEA, 99%, Sigma-Aldrich, St. Louis, MO, USA), toluene (Sigma-Aldrich), tetrahydrofuran (THF, Sinopharm, Beijing, China), and anisole (Sinopharm) were dried over CaH2 and distilled under nitrogen. MgSO4, n-hexane, acetonitrile (J&K Scientific Ltd, Beijing, China), stannous octoate (Sn(Oct)2, Sinopharm), 2-bromoisobutyryl bromide (98%, Alfa Aesar, Haverhill, MA, USA), CuBr2 and 1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA, 99%, Aldrich, St. Louis, MO, USA) were used as received. Ethidium bromide, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and IMQ (98% pure) were purchased from Sigma (St. Louis, MO, USA). Dulbecco’s modified Eagle medium (DMEM), fetal bovine serum (FBS), penicillin, and streptomycin were all purchased from Invitrogen (Carlsbad, CA, USA).

2.2. Synthesis of β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21

The amphiphilic pH-responsive star copolymer was synthesized by combining activator regenerated by electron-transfer atom-transfer radical polymerization (ARGET ATRP) with ring opening polymerization (ROP) [32]. First, the synthesis of β-CD-(PLA-OH)21 by ROP of d,l-LA (5.50 g, 37.8 mmol) in anhydrous toluene (25 mL) was carried out using β-CD (681 mg, 0.6 mmol) as an initiator and Sn(Oct)2 (65 µL, 0.2 mmol) as a catalyst at 130 °C for 24 h. The macroinitiator β-CD-(PLA-Br)21 was then synthesized from β-CD-(PLA-OH)21 (5.50 g, 0.6 mmol) and TEA (3.34 mL, 24 mmol) with 2-bromoisobutyryl bromide (2.97 mL, 24 mmol) in anhydrous THF (100 mL) at room temperature. Sequentially, monomer DMAEMA (7.07 mL, 42 mmol) and macroinitiator β-CD-(PLA-Br)21 (4.2 g, 0.4 mmol) were introduced to produce β-CD-(PLA-b-PDMAEMA)21 in 20 mL anhydrous toluene at 70 °C. A small amount of CuBr2 catalyst (6.7 mg, 0.03 mmol) and ligand HMTETA (76 µL, 0.3 mmol) were used together with a sufficiently large excess of reducing agent Sn(Oct)2 (97 µL, 0.30 mmol). Finally, β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 was polymerized in anhydrous anisole (20 mL) at 60 °C by adding EtOxMA (9.08 g, 11.34 mmol) and β-CD-(PLA-PDMAEMA-Br)21 (2.5 g, 0.06 mmol). The amount of CuBr2 catalyst and reducing agent Sn(Oct)2 was the same as β-CD-(PLA-b-PDMAEMA)21 polymerization with the exception of the ligand HMTETA (0.164 mL, 0.64 mmol). 1H NMR spectra were acquired in CDCl3 at 25 °C using a Bruker AVANCE ΙΙΙ 400 (Madison, WI, USA) operating at 400 MHz. 1H NMR of the final polymer product (CDCl3, δ, ppm): 5.17 (1H, CH of PLA), 4.05 (2H, –OCH2 of PDMAEMA), 3.44 (4H, N–CH2CH2 of PEtOxMA), 3.02 (3H, N–CH3 of PEtOxMA), 2.56 (2H, –CH2N of PDMAEMA), 2.30 (6H, –N(CH3)2 of PDMAEMA and PEtOxMA), 1.93 (6H, (CH3)2–Br), 1.70–1.90 (2H, –CH2CH3 of PDMAEMA and PEtOxMA), 1.55 (3H, CHCH3 of PLA), 0.81–1.10 (3H, –CH2CH3 of PDMAEMA and PEtOxMA).

2.3. Critical Micellar Concentration (CMC) Determination

Nile red was used as the fluorescent probe for CMC determination, starting from micellar solutions of varying concentrations ranging from 0.00025–20.0 mg/mL. To each sample, 20 μL of Nile red in acetone (3.0 × 10−4 M) was added to result in a final Nile red in water concentration of 1.5 × 10−6 M. After evaporating acetone overnight, the samples were equilibrated for three days. The fluorescence emission spectra were recorded between 525 and 750 nm with λex = 550 nm.

2.4. Preparation and Characterization of Blank and IMQ-Loaded Micelles

The blank and IMQ-loaded micelles were prepared using the diafiltration method [33,34,35]. To prepare IMQ-loaded micelles, IMQ (8 mg) was dissolved in 10 mL of DMSO. The polymer (40 mg) was dissolved in another 10 mL of DMSO, combined with the IMQ/DMSO solution, and stirred for 4 h. The IMQ/polymer/DMSO solution was then transferred to a dialysis bag (MW cut-off: 1 kDa) and dialyzed against 2 L of deionized water for 24 h to remove the DMSO and free drug. The deionized water was changed every 2 h for the first 6 h and then replaced every 6 h. After dialysis, the micelles were filtered through a membrane filter with 0.45-μm pores to remove aggregated particles and then collected by freeze-drying. The dried micelle product, as white powder, was stored at −20 °C. Blank micelles were prepared in the same way except without IMQ.
The average size and polydispersity index (PDI) of micelles were measured by dynamic light scattering (DLS) using a ZetaPlus particle analyzer (Brookhaven Instruments Corp., Holtsville, NY, USA; 27 mW laser; 658 nm incident beam, 90° scattering angle) at a polymer concentration of 0.1 mg/mL. Morphology of micelles at the same concentration was examined by transmission electron microscopy (TEM) using a Hitachi H-7650 microscope (Hitachi, Tokyo, Japan) operating at 80 kV. To investigate IMQ solubility, UV spectra of IMQ-loaded micelles in the 300–350 nm range were recorded using a BioTek Synergy HT microplate reader (BioTek Instruments, Winooski, VT, USA). To quantify IMQ loading, 2 mg of IMQ-loaded micelles were dissolved in 2 mL of DMSO and then analyzed to record UV absorbance at 318 nm using the same plate reader. The background of blank micelles in DMSO was subtracted. The amount of IMQ was calculated using a calibration curve constructed from measurements of samples with known concentrations of IMQ.
Dissipative particle dynamics (DPD) simulation, based on the coarse-grained models, was employed to gain deeper insight into the formation and microstructure of unimolecular micelles through simulating an aqueous solution of polymer with the same concentration as experiment (0.1 mg/mL). The interaction parameters were calculated according to our previous method [32,36]. DPD simulations were conducted in the Mesocite module at 298.15 K in Materials Studio 5.0 (Accelrys Inc., San Diego, CA, USA). A cubic simulation box of 37 × 37 × 37 rc3 with periodic boundary condition was applied in all three directions. The integration time step was 0.05 ns and the number of simulation steps was 100,000.

2.5. In Vitro Release Kinetics of IMQ

Release kinetics of IMQ from micelles was measured at different pHs: 7.4 (physiological pH) and 5.0 (mildly acidic pH of the endolysosomal compartment of cells), and a procedure of measurement was adapted from a method previously used for quantifying the release of water-insoluble doxorubicin from micelles [37,38]. Briefly, IMQ-loaded micelles were suspended at 1 mg/mL in a 20 mM phosphate buffer (pH 7.4) or acetate buffer (pH 5.0). Both solutions were stirred in a shaker at 37 °C. Absorbance of each solution was measured at 318 nm using a microplate reader (Synergy HT, BioTek) at predetermined time points. Each experiment was performed three times.

2.6. Preparation and Analyses of Micelle-DNA Complexes (Micelleplexes)

A plasmid containing the gene of green fluorescence protein (GFP) and a cytomegalovirus (CMV) promoter (pEGFP-N1) was used for evaluating micelleplex properties and gene transfection. Micelleplexes of N:P ratios ranging from 1/4 to 30 were prepared by adding 15 μL of micelle solution in 20 mM N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid (HEPES) (pH 7.4) to 15 μL of DNA solution (0.2 μg/μL in 20 mM HEPES, pH 7.4), vortexed for 10 s, and incubated for 30 min at room temperature. Both blank and IMQ-loaded micelles were used to prepare micelleplexes with plasmid DNA using the same procedure.
Gel retardation assay of micelleplexes of various N:P ratios was carried out by electrophoresis on a 1.0% agarose gel containing 0.5 μg/mL of ethidium bromide (EB). Exclusion of EB due to micellplex formation was quantified by measuring the fluorescence intensity of the dye using a Bio-Tek Synergy HT plate reader with excitation wavelength of 530/25 nm and emission wavelength of 590/35 nm. The results were presented as normalized percentages with measurement of the naked DNA/EB solution as 100% and that of the EB solution without DNA as 0%. The average size and PDI of micelleplexes in 20 mM HEPES buffer at 25 °C were determined using the same ZetaPlus particle analyzer mentioned above. Micelleplexes with N:P ratios ranging from 1–40 were prepared as described above and diluted 20 times to a final volume of 2 mL in HEPES buffer before measurement.

2.7. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) Assay

Murine DC2.4 cells (ATCC, Manassas, VA, USA) were seeded in a 96-well plate at a density of 1 × 104 cells/well in 200 µL of complete DC2.4 media (low-glucose DMEM, 10% FBS, 10 mM HEPES, 100 U/mL penicillin/streptomycin) and allowed to grow for 24 h to reach 60%–70% confluence. Each well was then replaced with 200 µL of micelleplex solutions of various N:P ratios and the treated cells were incubated in 5% CO2 at 37 °C for 24 h. This test was performed in replicates of six wells and cell viability was calculated as previously described [28].

2.8. In Vitro Gene Expression

The procedure was adapted from a previous report [28]. DC2.4 cells were seeded into 12-well plates at 100,000 cells/well and cultured in 5% CO2 and 37 °C overnight. After removing the cell media, cells were washed by phosphate buffered saline (PBS) twice followed by adding DC2.4 media without serum. Cells were then transfected for 4 h with micelleplexes of GFP plasmid at various N:P ratios either with or without IMQ loaded. After discarding the media, cells were washed with PBS twice and cultured in serum-containing media for another 20 h. The cells were harvested by treating with trypsin-ethylenediaminetetraacetic acid (EDTA), dispersed in fluorescence-activated cell sorting (FACS) buffer (PBS containing 1% bovine serum albumin), and analyzed using a flow cytometer (Accuri C6, BD Biosciences, San Jose, CA, USA). DC2.4 cells were also transfected with micelleplexes of a luciferase plasmid under the same conditions to exclude the autofluorescence of cells. The software FlowJo (Ashland, OR, USA) was utilized to determine the percentage of GFP+ cells and mean fluorescence intensity (MFI). The gate was drawn based on the luciferase control where false positive frequency was restricted to below 0.2%.

2.9. Statistical Analysis

Statistical analysis was carried out using a two-sample Student’s t-test with unequal variance. p < 0.05 was considered statistically significant.

3. Results and Discussion

3.1. Rationale of Polymer Design

The amphiphilic pH-responsive star block copolymer β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 was designed to form core-mesophere-shell-type unimolecular micelles as nanocarriers for loading and intracellular delivery of IMQ and plasmid DNA. The star polymer had a β-CD core and 21 arms, each consisting of blocks of PLA, PDMAEMA, and PEtOxMA, in that order. The innermost PLA block formed the hydrophobic core of the unimolecular micelle, in which the poorly-soluble IMQ could be encapsulated. The outermost block of PEtOxMA brushes formed the hydrophilic shell for stabilization, and could avoid unspecific interactions with the protein [39,40,41]. The middle block of pH-responsive PDMAEMA contains tertiary amines that become more protonated and cationic at mildly acidic pH, was expected to facilitate release of IMQ inside the endolysosome of dendritic cells where TLR7, the molecular target of IMQ, is located. This property of the PDMAEMA block should also enable binding, condensation, and intracellular release of the anionic plasmid DNA that culminate in the transfection of dendritic cells. These hypotheses were illustrated in Scheme 1.

3.2. Synthesis and Characterization of the Star Block Copolymer

Controlled living free radical polymerization techniques have been increasingly used in the synthesis of well-defined polymers for investigating structure-function relationship of drug and gene delivery systems [42,43,44,45,46]. We have reported recently multi-step synthesis of star block copolymers based unimolecular micelles as templates for in situ formation of gold nanoparticles [32]. Here, through combined use of ARGET ATRP and ROP, we have synthesized a new star block copolymer β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21, as shown in Scheme 2.
1H NMR spectra in Figure 1A displayed the characteristic proton peaks of PLA, accompanied by the disappearance of the peaks (4.43 and 5.66–5.71 ppm) from the hydroxyl groups of pristine β-CD, which confirmed the complete conversion of 21 hydroxyl groups of native β-CD to PLA arms. This observation was further supported by the disappearance of O–H stretching vibration (3330.66 cm−1) of β-CD after converting to β-CD-(PCL-OH)21 (carbonyl stretching vibration, 1765.08 cm−1) (Figure 1B). We then presented another 1H NMR spectra, which clearly showed characteristic chemical shifts of protons in the prepolymers and final polymer products (Figure 2). Through integrating the areas of characteristic peaks including the end-groups, the degree of polymerization (DP) of each block and molecular weight of the polymer product were estimated [47,48].
DPPLA = Ia/Ia’
DPPDMAEMA = If/Ia × 1/2
DPPEtOxMA = Il/Ia × 1/3
where Ia, Ia’, If, and Il are the intensity of the peaks at 5.17, 4.35, 4.05, and 3.02 ppm, respectively. Thus, the average molecular weight of the prepolymers and polymer product was obtained:
Mn β-CD-(PLA-OH)21 = DPPLA × 72 + 1135
Mn β-CD-(PLA-Br)21 = DPPLA × 72 + 4264
Mn β-CD-(PLA-b-PDMAEMA)21 = (DPPLA × 72 + DPPDMAEMA × 157) + 4264
Mn β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 = (DPPLA × 72 + DPPDMAEMA × 157+ DPPEtOxMA × 801) + 4264
where the molecular weights of β-CD, β-CD-(Br)21, d,l-LA, DMAEMA, and EtOxMA are 1135, 4264, 72, 157, and 801 g/mol, respectively. The DP of PLA, PDMAEMA, and PEtOxMA blocks were 6, 5 and 8, respectively, and the molecular weight values of β-CD-(PLA-OH)21, β-CD-(PLA-Br)21, β-CD-(PLA-b-PDMAEMA)21, and β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 determined by 1H NMR were 10,207, 13,336, 29,821, and 164,389 g/mol, respectively, demonstrating that the star polymer with high purity has been successfully synthesized.

3.3. Simulation and Characterization of Unimolecular Micelles

The experiment attempted for CMC determination was performed with Nile red as a fluorescent probe, which has low solubility in water and will be solubilized within the hydrophobic PLA core [25]. Figure 3 showed that the fluorescence emission intensity of Nile red at 620 nm increased with increasing star polymer concentration, even at extremely low polymer concentrations. No abrupt changes in fluorescence intensity were observed throughout the entire range of polymer concentration, indicating the absence of a CMC in water and, thus, confirming the existence of unimolecular micelles.
To gain insight on the solution behavior of the star block copolymer and formation of micelles, DPD simulation was conducted using the same polymer concentration as in actual experiments (0.1 mg/mL). The hydrophobic block, pH-responsive block, and hydrophilic block of the star polymer were shown in green, pink, and blue color, respectively, while water beads (grey color) were hidden for clarity. Shown in Figure 4A, the simulation started with 11 star polymer molecules dispersed randomly in the box. As the system moved toward equilibrium, 11 discrete micelles were observed. The number of micelles was the same of the number of polymer molecules, evidence that these were unimolecular micelles. With the elapsing time of simulation, the surface of the micelles became smoother and more spherical. The radius of gyration of EtOxMA increased gradually and then became stable, while the radius of gyration of DMAEMA and d,l-LA remained unchanged, which may due to the fact that the extension of long hydrophilic EtOxMA results in the mild increase of the micellar size (Figure 4B). The hydrophilic EtOxMA are of good compatibility with water and abundant quantity (one polymer molecule contained 1176 EtOxMA beads), while the number of both hydrophobic d,l-LA beads and the DMAEMA beads were 63 and 105, respectively. Therefore, the aggregation contributed by hydrophobic effect was avoided in our micelle system, which existed as core-mesophere-shell-type unimolecular micelles with PLA block as hydrophobic core, PDMAEMA as the middle layer, and dense PEtOxMA brushes as the hydrophilic shell to maintain colloidal stability in water.
Experimentally, the star block copolymer β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 dissolved well in water. DLS measurement detected a single population of nanoparticles with an average hydrodynamic diameter Dh of approximately 19 nm and a narrow size distribution (PDI 0.218) (Figure 5A). Zeta potential value of the unimolecular micelles is 7.13 ± 1.35 mV. These nanoparticles remained stable in water without aggregation for as long as one month. TEM revealed that the star block copolymer formed discrete, largely-spherical unimolecular micelles with an average size of 15 nm (Figure 5B), slightly smaller than DLS measurement of hydrated particles [49,50]. Taken together, results from computer simulation and experiments point to the formation of unimolecular micelles in the aqueous solution.

3.4. IMQ Loading and pH-Responsive Release Kinetics

To evaluate the enhancement of IMQ solubility through micelle encapsulation, samples of free IMQ in water and IMQ loaded on micelles with equivalent IMQ content were analyzed. Blank micelles without IMQ did not absorb in this range of wavelength at all. Free IMQ showed insignificant absorbance in the range of 300–350 nm, due to low solubility in water at neutral pH (4.5 μg/mL) [21]. In contrast, IMQ loaded in micelles had higher adsorption in 300–330 nm with a prominent peak at 318 nm (Figure 6A), which the encapsulation in the unimolecular micelles enhanced the solubility of IMQ 12 fold, to 54 μg/mL, suggesting this unimolecular micelle system is better than the previously reported micelle system [21].
After IMQ loading, the size of the unimolecular micelles grew larger to an average diameter of 28 nm (by DLS) (Figure 5C) and 23 nm (by TEM), but the shape of the IMQ-loaded micelles was still round (Figure 5D). The increase of micelle size after drug loading was often explained by the extra volume needed for orderly packed polymer chains to accommodate drug molecules inside the micelles. It might also be due to drug-induced micelle aggregation. The amount of drug loading was 1.6 wt %. This value is slightly higher than a recently reported multimolecular polymer micelle system with PLA cores (1.2 wt %) [22]. Compared with multimolecular micelles, unimolecular micelles are generally expected to have smaller cores and, hence, lower encapsulation capacity. However, the PDMAEMA middle block of our star polymer might have contributed to higher drug loading observed here.
In vitro release kinetics of IMQ from the micelles was investigated. We showed in Figure 6A that IMQ had high absorbance at 318 nm when encapsulated in micelles, but when the drug was released into water, the absorbance at 318 nm was much reduced. This served as the basis for quantification of IMQ release from the hydrophilic core of the micelles into the hydrophilic environment of the water. When IMQ was still trapped in the micelles, UV absorbance at 318 nm was high. This was defined as 0% release. When all IMQ was released as free IMQ, UV absorbance at 318 nm was almost zero. This was defined as 100% release. As IMQ was released gradually, UV absorbance at 318 nm gradually decreased from the intensity of 0% release to 100% release. Thus, the time dependent reduction of IMQ absorbance at 318 was monitored at various time points until no further change occurred. Precisely because of this property of IMQ, we were able to quantify IMQ release into water more conveniently without having to separate free IMQ from IMQ-loaded micelles.
Figure 6B clearly showed that IMQ release from micelles was faster at slightly acidic pH. At pH 7.4, the release of IMQ was about 8% in 0.5 h, 15% in 1 h, and 44% after 120 h, owing to the slightly tight structure of the unimolecular micelles. The burst release including the first 0.5 h was found at this pH due to IMQ molecules located within the hydrophilic shell or at the interface between the hydrophilic shell and cationic middle layer, thus initial water penetration may have caused some IMQ to be released [51]. At pH 5.0, however, the release was about 35% in 0.5 h, 40% in 1 h and 70% after 120 h. This may be due to the fact that as the tertiary amine groups of the PDMAEMA block (pKa = 7.0) were protonated at pH 5.0, the reduction in hydrophobicity caused swelling of the micelles, and the entrapped IMQ could be released at an accelerated rate [52,53]. Moreover, the higher solubility of the IMQ in acidic medium (due to protonated amine in IMQ, pKa = 7.3) might have minor contribution to the faster release kinetics at pH 5.0. In addition, as reported in the literature with protonated amine-containing segments [54,55], we expect that the size of IMQ-loaded micelles with PDMAEMA block might become larger at acidic pH, which could be an another reason for the faster release. Based on these observations, it is reasonable to speculate that the IMQ-loaded pH-responsive unimolecular micelles with small particle size (<50 nm) and colloidal stability would be efficiently taken up by dendritic cells through multiple pathways, such as pinocytosis and phagocytosis, and subsequently release IMQ in the acidic endolysosome to engage in TLR7 signaling, as suggested by a previous report on acid-labile dextran microspheres [20]. To further reduce burst release in these polymer micelles, our future studies may use a longer pH-sensitive middle block or introduce crosslinks to stabilize the micelles.

3.5. Micelleplex Formation between Plasmid DNA and Star Polymer Micelles with and without IMQ

We hypothesize that the cationic PDMAEMA block of the star polymer should enable binding and condensation of plasmid DNA into micelleplexes. To assess DNA binding, a gel retardation assay was performed. Plasmid DNA migration through an agarose gel in the presence of blank micelles was completely retarded at N:P ratio of 2:1 or higher (Figure 7A). On the other hand, with IMQ-loaded micelles, complete retardation of plasmid DNA occurred at N:P ratios of 5:1 or higher. It is possible that IMQ encapsulation occupied part of the cationic PDMAEMA block, and, therefore, required a higher N:P ratio to achieve the same degree of DNA binding as the blank micelles. DNA condensation by micelles resulted in the exclusion of EB, a DNA-binding fluorescent dye, and quenching of its fluorescence. Both blank and IMQ-loaded micelles needed N:P ratios of at least 2:1–5:1 for maximal quenching of EB (Figure 7B). DLS experiments detected micelleplexes with average diameters ranging from 150–400 nm, depending on the N:P ratio, with PDI ranging from 0.1–0.4 (Figure 7C). There appeared to be a particle size maximum of 350–400 nm for blank and IMQ-loaded micelleplexes at N:P ratios of 5:1 and 10:1, respectively. A further increase in the N:P ratio led to smaller, presumably more tightly packed, micelleplexes. TEM of both blank and IMQ-loaded micelleplexes at N:P ratio of 20:1 showed round, discrete, nanoparticles having average size of 150–200 nm, with the IMQ-loaded micelleplexes being slightly larger (190 nm) than blank micelleplexes (155 nm) (Figure 7D,E). When dried for TEM, the micelleplexes appeared much smaller than those swollen in aqueous buffer as measured by DLS (300–350 nm).
Collectively, these results confirm the hypothesis that the unimolecular micelles were capable of binding and condensing plasmid DNA into discrete nano-scale micelleplexes. Having a hydrophilic outer shell of PEOxMA brushes did not prevent complexing with DNA, although it did require N:P ratio at least 5:1 or higher to form compact micelleplexes. Loading IMQ in the micelle core reduced only slightly the abilities of DNA binding and condensation, and it led to slightly larger micelleplexes than without the IMQ. Thus, it appears that combined loading of IMQ and plasmid DNA onto the same micelles is feasible without any mutual interference, likely because the two cargos are spatially segregated—with the IMQ partitioning into the hydrophobic core and the plasmid DNA interacting with the cationic middle segment.

3.6. Transfection of DCs by Micelleplexes with and without IMQ

Transfection efficiency of the micelleplexes was assessed in mouse dendritic cell line (DC2.4) with GFP as a reporter. Transfection was conducted for 4 h in cell media without serum and expression of GFP quantified by flow cytometry after 20 h of culture with serum-containing media. Micelleplexes were prepared using N:P ratios of 5:1 through 30:1, either with or without loading of IMQ. A cytotoxicity assay showed that micelleplexes with N:P ratios of up to 20:1 maintained greater than 90% cell viability with the exception of N:P ratio of 30:1 (70% viability) (Figure S1). Special care was taken to avoid false positive signals of GFP positive cells due to potential changes in cell autofluorescence after treatment with the polymer. Figure 8A showed that 6%–14% DCs were transfected by micelleplexes. Higher N:P ratios resulted in higher percentages of GFP+ cells and higher MFI. IMQ loading did not significantly alter the transfection efficiency, with the exception of the N:P ratio of 30:1, which resulted in statistically significant (p < 0.05) increases of the fraction of GFP+ cells and MFI (Figure 8B). This finding confirms that encapsulating IMQ in the hydrophobic core of the micelles has no negative impact on the function of the micelles as gene carriers, consistent with our other observations that IMQ-loading caused only minor changes in DNA binding, condensation, and micelleplex size and morphology. It also implies that, within the time frame of the experiment (24 h), IMQ and TLR7 signaling have not produced any biological changes in the cells that might impede intracellular gene delivery processes mediated by this particular amphiphilic star block copolymer. Whether this conclusion holds true for other polymeric gene carriers with different chemical composition and architecture is a question that requires further study. Moreover, the importance of dosing and release kinetics of IMQ co-delivered with plasmid DNA in stimulating DC maturation and antigen expression will be investigated in the future.

4. Conclusions

An amphiphilic pH-responsive star block copolymer has been designed to serve as a nano-scale vehicle for combined loading and delivery of IMQ and plasmid DNA. Living polymerization methods (ARGET ATRP and ROP) were used to precisely control the chain length and composition of the star polymer. The polymer formed small, narrowly-dispersed unimolecular micelles in an aqueous buffer. Solubility of IMQ had been much enhanced by encapsulating in the PLA core of the micelle. The release of IMQ could be accelerated at mildly acidic pH, owing to the pH-responsive protonation of the PDMAEMA block of the micelles. These micelles were also capable of forming nano-scale micelleplexes with plasmid DNA and transfecting dendritic cells in vitro. IMQ-loading had a moderate impact on the formation and size of micelleplexs, but the gene transfection capacity of the micelleplexes remained intact. With further optimization, this well-defined pH-responsive star block copolymer, with its dual capacities of loading IMQ and plasmid DNA, could be useful nano-carriers for potential synergistic delivery of gene-based immunotherapeutics and vaccines.

Supplementary Materials

The following are available online at www.mdpi.com/2073-4360/8/11/397/s1, Figure S1: In vitro cytotoxicity of micelleplexes after 24 h incubation at different N:P ratios determined by MTT assay against DC 2.4 cells (n = 6).

Acknowledgments

This work was financially supported by National Natural Science Foundation of China (No. 91434125), Team Project of Natural Science Foundation of Guangdong Province, China (No. S2011030001366), Science and Technology Foundation of Guangdong Province (No. 2015B020237008), and the University of Minnesota. Wenjing Lin thanks the China Scholarship Council (CSC) (No. 201406150021) for a fellowship to support her 1-year stay at the University of Minnesota.

Author Contributions

Wenjing Lin, Chun Wang, and Lijuan Zhang conceived and designed the experiments as well as wrote the paper; Wenjing Lin and Na Yao performed the synthesis experiments and physico-chemical characterization; Wenjing Lin, Samuel Hanson, and Wenqing Han carried out the cell experiments; Wenjing Lin, Hongru Li, Chun Wang, and Lijuan Zhang analyzed the data.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Singh, M.; O’Hagan, D. Advances in vaccine adjuvants. Nat. Biotechnol. 1999, 17, 1075–1081. [Google Scholar] [CrossRef] [PubMed]
  2. O’Hagan, D.T.; Valiante, N.M. Recent advances in the discovery and delivery of vaccine adjuvants. Nat. Rev. Drug Discov. 2003, 2, 727–735. [Google Scholar] [CrossRef] [PubMed]
  3. Reed, S.G.; Bertholet, S.; Coler, R.N.; Friede, M. New horizons in adjuvants for vaccine development. Trends Immunol. 2009, 30, 23–32. [Google Scholar] [CrossRef] [PubMed]
  4. Alving, C.R.; Peachman, K.K.; Rao, M.; Reed, S.G. Adjuvants for human vaccines. Curr. Opin. Immunol. 2012, 24, 310–315. [Google Scholar] [CrossRef] [PubMed]
  5. Mbow, M.L.; De Gregorio, E.; Valiante, N.M.; Rappuoli, R. New adjuvants for human vaccines. Curr. Opin. Immunol. 2010, 22, 411–416. [Google Scholar] [CrossRef] [PubMed]
  6. Kool, M.; Fierens, K.; Lambrecht, B.N. Alum adjuvant: Some of the tricks of the oldest adjuvant. J. Med. Microbiol. 2012, 61, 927–934. [Google Scholar] [CrossRef] [PubMed]
  7. Rappuoli, R.; Mandl, C.W.; Black, S.; De Gregorio, E. Vaccines for the twenty-first century society. Nat. Rev. Immunol. 2011, 11, 865–872. [Google Scholar] [CrossRef] [PubMed]
  8. Fox, C.B.; Haensler, J. An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. J. Expert Rev. Vaccine 2013, 12, 747–758. [Google Scholar] [CrossRef] [PubMed]
  9. Rice-Ficht, A.C.; Arenas-Gamboa, A.M.; Kahl-McDonagh, M.M.; Ficht, T.A. Polymeric particles in vaccine delivery. Curr. Opin. Microbiol. 2010, 13, 106–112. [Google Scholar] [CrossRef] [PubMed]
  10. Kasturi, S.P.; Skountzou, I.; Albrecht, R.A.; Koutsonanos, D.; Hua, T.; Nakaya, H.I.; Ravindran, R.; Stewart, S.; Alam, M.; Kwissa, M. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 2011, 470, 543–547. [Google Scholar] [CrossRef] [PubMed]
  11. Ataman-Önal, Y.; Munier, S.; Ganée, A.; Terrat, C.; Durand, P.Y.; Battail, N.; Martinon, F.; Le Grand, R.; Charles, M.H.; Delair, T.; et al. Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J. Control. Release 2006, 112, 175–185. [Google Scholar] [CrossRef] [PubMed]
  12. Thomsen, L.L.; Topley, P.; Daly, M.G.; Brett, S.J.; Tite, J.P. Imiquimod and resiquimod in a mouse model: Adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery. Vaccine 2004, 22, 1799–1809. [Google Scholar] [CrossRef] [PubMed]
  13. Burns, R.P.; Ferbel, B.; Tomai, M.; Miller, R.; Gaspari, A.A. The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans’ cells. Clin. Immunol. 2000, 94, 13–23. [Google Scholar] [CrossRef] [PubMed]
  14. Chollet, J.L.; Jozwiakowski, M.J.; Phares, K.R.; Reiter, M.J.; Roddy, P.J.; Schultz, H.J.; Ta, Q.V.; Tomai, M.A. Development of a topically active imiquimod formulation. Pharm. Dev. Technol. 1999, 4, 35–43. [Google Scholar] [CrossRef] [PubMed]
  15. Beutner, K.R.; Spruance, S.L.; Hougham, A.J.; Fox, T.L.; Owens, M.L.; Douglas, J.M. Treatment of genital warts with an immune-response modifier (imiquimod). J. Am. Acad. Dermatol. 1998, 38, 230–239. [Google Scholar] [CrossRef]
  16. Tyring, S. Imiquimod applied topically: A novel immune response modifier. Skin Ther. Lett. 2001, 6, 1–4. [Google Scholar]
  17. Larangé, A.; Antonios, D.; Pallardy, M.; Kerdine-Römer, S. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation. J. Leukoc. Biol. 2009, 85, 673–683. [Google Scholar] [CrossRef] [PubMed]
  18. Suzuki, H.; Wang, B.; Shivji, G.M.; Toto, P.; Amerio, P.; Tomai, M.A.; Miller, R.L.; Sauder, D.N. Imiquimod, a topical immune response modifier, induces migration of langerhans cells. J. Investig. Dermatol. 2000, 114, 135–141. [Google Scholar] [CrossRef] [PubMed]
  19. Walter, A.; Schäfer, M.; Cecconi, V.; Matter, C.; Urosevic-Maiwald, M.; Belloni, B.; Schönewolf, N.; Dummer, R.; Bloch, W.; Werner, S. Aldara activates TLR7-independent immune defence. Nat. Commun. 2013, 4, 1560. [Google Scholar] [CrossRef] [PubMed]
  20. Bachelder, E.M.; Beaudette, T.T.; Broaders, K.E.; Fréchet, J.M.; Albrecht, M.T.; Mateczun, A.J.; Ainslie, K.M.; Pesce, J.T.; Keane-Myers, A.M. In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants. Mol. Pharm. 2010, 7, 826–835. [Google Scholar] [CrossRef] [PubMed]
  21. Handké, N.; Lahaye, V.; Bertin, D.; Delair, T.; Verrier, B.; Gigmes, D.; Trimaille, T. Elaboration of glycopolymer-functionalized micelles from an N-vinylpyrrolidone/lactide-based reactive copolymer platform. Macromol. Biosci. 2013, 13, 1213–1220. [Google Scholar] [CrossRef] [PubMed]
  22. Jiménez-Sánchez, G.; Pavot, V.; Chane-Haong, C.; Handké, N.; Terrat, C.; Gigmes, D.; Trimaille, T.; Verrier, B. Preparation and in vitro evaluation of imiquimod loaded polylactide-based micelles as potential vaccine adjuvants. Pharm. Res. 2015, 32, 311–320. [Google Scholar] [CrossRef] [PubMed]
  23. Gao, H. Development of star polymers as unimolecular containers for nanomaterials. Macromol. Rapid Commun. 2012, 33, 722–734. [Google Scholar] [CrossRef] [PubMed]
  24. Satoh, T. Unimolecular micelles based on hyperbranched polycarbohydrate cores. Soft Matter 2009, 5, 1972–1982. [Google Scholar] [CrossRef]
  25. Knop, K.; Pretzel, D.; Urbanek, A.; Rudolph, T.; Scharf, D.H.; Schallon, A.; Wagner, M.; Schubert, S.; Kiehntopf, M.; Brakhage, A.A. Star-shaped drug carriers for doxorubicin with POEGMA and POEtOxMA brush-like shells: A structural, physical, and biological comparison. Biomacromolecules 2013, 14, 2536–2548. [Google Scholar] [CrossRef] [PubMed]
  26. Pang, X.; Zhao, L.; Han, W.; Xin, X.; Lin, Z. A general and robust strategy for the synthesis of nearly monodisperse colloidal nanocrystals. Nat. Nanotechnol. 2013, 8, 426–431. [Google Scholar] [CrossRef] [PubMed]
  27. Nguyen, D.N.; Green, J.J.; Chan, J.M.; Langer, R.; Anderson, D.G. Polymeric materials for gene delivery and DNA vaccination. Adv. Mater. 2009, 21, 847–867. [Google Scholar] [CrossRef]
  28. Ji, W.; Panus, D.; Palumbo, R.N.; Tang, R.; Wang, C. Poly(2-aminoethyl methacrylate) with well-defined chain length for DNA vaccine delivery to dendritic cells. Biomacromolecules 2011, 12, 4373–4385. [Google Scholar] [CrossRef] [PubMed]
  29. DeMuth, P.C.; Min, Y.; Huang, B.; Kramer, J.A.; Miller, A.D.; Barouch, D.H.; Hammond, P.T.; Irvine, D.J. Polymer multilayer tattooing for enhanced DNA vaccination. Nat. Mater. 2013, 12, 367–376. [Google Scholar] [CrossRef] [PubMed]
  30. Cui, L.; Osada, K.; Imaizumi, A.; Kataoka, K.; Nakano, K. Feasibility of a subcutaneously administered block/homo-mixed polyplex micelle as a carrier for DNA vaccination in a mouse tumor model. J. Control. Release 2015, 206, 220–231. [Google Scholar] [CrossRef] [PubMed]
  31. Tsen, S.W.D.; Paik, A.H.; Hung, C.F.; Wu, T. Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells. Expert Rev. Vaccines 2007, 6, 227–239. [Google Scholar] [CrossRef] [PubMed]
  32. Yao, N.; Lin, W.; Zhang, X.; Gu, H.; Zhang, L. Amphiphilic β-cyclodextrin-based star-like block copolymer unimolecular micelles for facile in situ preparation of gold nanoparticles. J. Polym. Sci. A Polym. Chem. 2016, 54, 186–196. [Google Scholar] [CrossRef]
  33. Yang, Y.Q.; Zheng, L.S.; Guo, X.D.; Qian, Y.; Zhang, L.J. pH-sensitive micelles self-assembled from amphiphilic copolymer brush for delivery of poorly water-soluble drugs. Biomacromolecules 2010, 12, 116–122. [Google Scholar] [CrossRef] [PubMed]
  34. Lin, W.J.; Nie, S.Y.; Xiong, D.; Guo, X.D.; Wang, J.F.; Zhang, L.J. pH-Responsive micelles based on (PCL)2(PDEA-b-PPEGMA)2 miktoarm polymer: Controlled synthesis, characterization, and application as anticancer drug carrier. Nanoscale Res. Lett. 2014, 9, 1–12. [Google Scholar] [CrossRef] [PubMed]
  35. Tian, S.; Liu, G.; Wang, X.; Zhang, G.; Hu, J. pH-Responsive tumor-targetable theranostic nanovectors based on core crosslinked (CCL) micelles with fluorescence and magnetic resonance (MR) dual imaging modalities and drug delivery performance. Polymers 2016, 8, 226. [Google Scholar] [CrossRef]
  36. Zhang, X.F.; Lin, W.J.; Wen, L.Y.; Yao, N.; Nie, S.Y.; Zhang, L.J. Systematic design and application of unimolecular star-like block copolymer micelles: A coarse-grained simulation study. Phys. Chem. Chem. Phys. 2016, 18, 26519–26529. [Google Scholar] [CrossRef] [PubMed]
  37. Gillies, E.R.; Jonsson, T.B.; Fréchet, J.M. Stimuli-responsive supramolecular assemblies of linear-dendritic copolymers. J. Am. Chem. Soc. 2004, 126, 11936–11943. [Google Scholar] [CrossRef] [PubMed]
  38. De Gracia Lux, C.; Joshi-Barr, S.; Nguyen, T.; Mahmoud, E.; Schopf, E.; Fomina, N.; Almutairi, A. Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. J. Am. Chem. Soc. 2012, 134, 15758–15764. [Google Scholar] [CrossRef] [PubMed]
  39. Luxenhofer, R.; Han, Y.; Schulz, A.; Tong, J.; He, Z.; Kabanov, A.V.; Jordan, R. Poly(2-oxazoline)s as polymer therapeutics. Macromol. Rapid Commun. 2012, 33, 1613–1631. [Google Scholar] [CrossRef] [PubMed]
  40. Zhang, N.; Pompe, T.; Amin, I.; Luxenhofer, R.; Werner, C.; Jordan, R. Tailored poly(2-oxazoline) polymer brushes to control protein adsorption and cell adhesion. Macromol. Biosci. 2012, 12, 926–936. [Google Scholar] [CrossRef] [PubMed]
  41. He, Z.; Miao, L.; Jordan, R.; S-Manickam, D.; Luxenhofer, R.; Kabanov, A.V. A low protein binding cationic poly(2-oxazoline) as non-viral vector. Macromol. Biosci. 2015, 15, 1004–1020. [Google Scholar] [CrossRef] [PubMed]
  42. Chu, D.S.; Schellinger, J.G.; Shi, J.; Convertine, A.J.; Stayton, P.S.; Pun, S.H. Application of living free radical polymerization for nucleic acid delivery. Acc. Chem. Res. 2012, 45, 1089–1099. [Google Scholar] [CrossRef] [PubMed]
  43. Wang, C.E.; Wei, H.; Tan, N.; Boydston, A.J.; Pun, S.H. Sunflower polymers for folate-mediated drug delivery. Biomacromolecules 2015, 17, 69–75. [Google Scholar] [CrossRef] [PubMed]
  44. Jiang, X.; Lok, M.C.; Hennink, W.E. Degradable-brushed pHEMA–pDMAEMA synthesized via ATRP and click chemistry for gene delivery. Bioconjug. Chem. 2007, 18, 2077–2084. [Google Scholar] [CrossRef] [PubMed]
  45. Palumbo, R.N.; Zhong, X.; Panus, D.; Han, W.; Ji, W.; Wang, C. Transgene expression and local tissue distribution of naked and polymer-condensed plasmid DNA after intradermal administration in mice. J. Control. Release 2012, 159, 232–239. [Google Scholar] [CrossRef] [PubMed]
  46. Bastakoti, B.P.; Wu, K.C.W.; Inoue, M.; Yusa, S.I.; Nakashima, K.; Yamauchi, Y. Multifunctional core-shell-corona-type polymeric micelles for anticancer drug-delivery and imaging. Chem. Eur. J. 2013, 19, 4812–4817. [Google Scholar] [CrossRef] [PubMed]
  47. Zhu, W.; Nese, A.; Matyjaszewski, K. Thermoresponsive star triblock copolymers by combination of ROP and ATRP: From micelles to hydrogels. J. Polym. Sci. A Polym. Chem. 2011, 49, 1942–1952. [Google Scholar] [CrossRef]
  48. Yang, Y.Q.; Lin, W.J.; Zhao, B.; Wen, X.F.; Guo, X.D.; Zhang, L.J. Synthesis and physicochemical characterization of amphiphilic triblock copolymer brush containing pH-sensitive linkage for oral drug delivery. Langmuir 2012, 28, 8251–8259. [Google Scholar] [CrossRef] [PubMed]
  49. Jiang, J.; Liu, Y.; Gong, Y.; Shu, Q.; Yin, M.; Liu, X.; Chen, M. pH-Induced outward movement of star centers within coumarin-centered star-block polymer micelles. Chem. Commun. 2012, 48, 10883–10885. [Google Scholar] [CrossRef] [PubMed]
  50. Yin, H.; Kang, H.C.; Huh, K.M.; Bae, Y.H. Biocompatible, pH-sensitive AB2 miktoarm polymer-based polymersomes: Preparation, characterization, and acidic pH-activated nanostructural transformation. J. Mater. Chem. 2012, 22, 19168–19178. [Google Scholar] [CrossRef] [PubMed]
  51. Prabaharan, M.; Grailer, J.J.; Pilla, S.; Steeber, D.A.; Gong, S. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn® H40, poly(l-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. Biomaterials 2009, 30, 3009–3019. [Google Scholar] [CrossRef] [PubMed]
  52. Hu, J.; Zhang, G.; Ge, Z.; Liu, S. Stimuli-responsive tertiary amine methacrylate-based block copolymers: Synthesis, supramolecular self-assembly and functional applications. Prog. Polym. Sci. 2014, 39, 1096–1143. [Google Scholar] [CrossRef]
  53. Luo, C.; Liu, Y.; Li, Z. Pathway-dependent re-assembly of dual-responsive ABC terpolymer in water. Soft Matter 2012, 8, 2618–2626. [Google Scholar] [CrossRef]
  54. Lin, W.J.; Nie, S.Y.; Zhong, Q.; Yang, Y.Q.; Cai, C.Z.; Wang, J.F.; Zhang, L.J. Amphiphilic miktoarm star copolymer (PCL)3-(PDEAEMA-b-PPEGMA)3 as pH-sensitive micelles in the delivery of anticancer drug. J. Mater. Chem. B 2014, 2, 4008–4020. [Google Scholar] [CrossRef]
  55. Yuan, W.; Zhang, J.; Wei, J.; Zhang, C.; Ren, J. Synthesis and self-assembly of pH-responsive amphiphilic dendritic star-block terpolymer by the combination of ROP, ATRP and click chemistry. Eur. Polym. J. 2011, 47, 949–958. [Google Scholar] [CrossRef]
Polymers 08 00397 sch001 550
Scheme 1. Schematic illustration of co-delivery of IMQ (red triangles) and plasmid DNA to dendritic cells via unimolecular micelles formed by the amphiphilic pH-responsive star polymer β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21.
Scheme 1. Schematic illustration of co-delivery of IMQ (red triangles) and plasmid DNA to dendritic cells via unimolecular micelles formed by the amphiphilic pH-responsive star polymer β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21.
Polymers 08 00397 sch001
Polymers 08 00397 sch002 550
Scheme 2. Schematic illustration of the synthesis of β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21.
Scheme 2. Schematic illustration of the synthesis of β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21.
Polymers 08 00397 sch002
Polymers 08 00397 g001 550
Figure 1. The complete conversion of 21 hydroxyl groups of pristine β-CD to PLA arms. (A) 1H NMR spectra of β-CD in DMSO-d6 and β-CD-(PCL-OH)21 in CDCl3; (B) FT IR spectra of β-CD and β-CD-(PCL-OH)21.
Figure 1. The complete conversion of 21 hydroxyl groups of pristine β-CD to PLA arms. (A) 1H NMR spectra of β-CD in DMSO-d6 and β-CD-(PCL-OH)21 in CDCl3; (B) FT IR spectra of β-CD and β-CD-(PCL-OH)21.
Polymers 08 00397 g001
Polymers 08 00397 g002 550
Figure 2. 1H NMR spectra of β-CD-(PLA-OH)21 (A); β-CD-(PLA-Br)21 (B); β-CD-(PLA-b-PDMAEMA)21 (C); and β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 (D) in CDCl3.
Figure 2. 1H NMR spectra of β-CD-(PLA-OH)21 (A); β-CD-(PLA-Br)21 (B); β-CD-(PLA-b-PDMAEMA)21 (C); and β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 (D) in CDCl3.
Polymers 08 00397 g002
Polymers 08 00397 g003 550
Figure 3. Intensity of the fluorescence emission of Nile red at 620 nm (λex = 550 nm; slit widths: Ex. 5 nm, Em. 5 nm) as a function of concentration of β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 as well as an expanded view of the low concentration range (inset).
Figure 3. Intensity of the fluorescence emission of Nile red at 620 nm (λex = 550 nm; slit widths: Ex. 5 nm, Em. 5 nm) as a function of concentration of β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 as well as an expanded view of the low concentration range (inset).
Polymers 08 00397 g003
Polymers 08 00397 g004 550
Figure 4. DPD simulation of β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 at different simulation times at experimental concentration of 0.1 mg/mL. (A) Formation process. (B) Radius of gyration of EtOxMA, DMAEMA, and d,l-LA.
Figure 4. DPD simulation of β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 at different simulation times at experimental concentration of 0.1 mg/mL. (A) Formation process. (B) Radius of gyration of EtOxMA, DMAEMA, and d,l-LA.
Polymers 08 00397 g004
Polymers 08 00397 g005 550
Figure 5. DLS plots (A,C) and TEM images (B,D, discrete and spherical blackspots) of blank (A,B) and IMQ-loaded (C,D) β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 micelles.
Figure 5. DLS plots (A,C) and TEM images (B,D, discrete and spherical blackspots) of blank (A,B) and IMQ-loaded (C,D) β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 micelles.
Polymers 08 00397 g005
Polymers 08 00397 g006 550
Figure 6. Enhancement of solubility and accelerated release of IMQ through encapsulation in β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 unimolecular micelles. (A) UV spectra of the IMQ-loaded micelles solution, water-IMQ solution, and blank micelle solution, pH 7.4; (B) In vitro release profiles of IMQ from micelles at pH 7.4 and 5.0.
Figure 6. Enhancement of solubility and accelerated release of IMQ through encapsulation in β-CD-(PLA-b-PDMAEMA-b-PEtOxMA)21 unimolecular micelles. (A) UV spectra of the IMQ-loaded micelles solution, water-IMQ solution, and blank micelle solution, pH 7.4; (B) In vitro release profiles of IMQ from micelles at pH 7.4 and 5.0.
Polymers 08 00397 g006
Polymers 08 00397 g007 550
Figure 7. DNA binding, condensation by micelles, and size and morphology of micelleplexes with or without loading of IMQ. (A) Gel retardation assay; (B) ethidium bromide (EB) exclusion; (C) average particle size by DLS; TEM images of blank micelleplexes (D); and IMQ-loaded micelleplexes (E) at N:P = 20 (The discrete and spherical blackspots represented corresponding micelleplexes).
Figure 7. DNA binding, condensation by micelles, and size and morphology of micelleplexes with or without loading of IMQ. (A) Gel retardation assay; (B) ethidium bromide (EB) exclusion; (C) average particle size by DLS; TEM images of blank micelleplexes (D); and IMQ-loaded micelleplexes (E) at N:P = 20 (The discrete and spherical blackspots represented corresponding micelleplexes).
Polymers 08 00397 g007
Polymers 08 00397 g008 550
Figure 8. Transfection efficiency of DC2.4 cells by micelleplexes determined by flow cytometry. Quantification by the percentage of transfected GFP+ cells (A) and mean fluorescence intensity (B). * p < 0.05.
Figure 8. Transfection efficiency of DC2.4 cells by micelleplexes determined by flow cytometry. Quantification by the percentage of transfected GFP+ cells (A) and mean fluorescence intensity (B). * p < 0.05.
Polymers 08 00397 g008

Share and Cite

MDPI and ACS Style

Lin, W.; Yao, N.; Li, H.; Hanson, S.; Han, W.; Wang, C.; Zhang, L. Co-Delivery of Imiquimod and Plasmid DNA via an Amphiphilic pH-Responsive Star Polymer that Forms Unimolecular Micelles in Water. Polymers 2016, 8, 397. https://0-doi-org.brum.beds.ac.uk/10.3390/polym8110397

AMA Style

Lin W, Yao N, Li H, Hanson S, Han W, Wang C, Zhang L. Co-Delivery of Imiquimod and Plasmid DNA via an Amphiphilic pH-Responsive Star Polymer that Forms Unimolecular Micelles in Water. Polymers. 2016; 8(11):397. https://0-doi-org.brum.beds.ac.uk/10.3390/polym8110397

Chicago/Turabian Style

Lin, Wenjing, Na Yao, Hongru Li, Samuel Hanson, Wenqing Han, Chun Wang, and Lijuan Zhang. 2016. "Co-Delivery of Imiquimod and Plasmid DNA via an Amphiphilic pH-Responsive Star Polymer that Forms Unimolecular Micelles in Water" Polymers 8, no. 11: 397. https://0-doi-org.brum.beds.ac.uk/10.3390/polym8110397

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop